VCP
SNY icon

Verus Capital Partners’s Sanofi SNY Stock Holding History

Verus Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$23K Sell
530
-928
-64% -$44.4K 0.01% 770
2019
Q4 		$73K Buy
+1,458
New +$68.3K 0.02% 479

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Verus Capital Partners's SNY Position: Q1 2020 in Review

Verus Capital Partners reduced its Sanofi (SNY) stake by 64% in Q1 2020, selling an estimated $44.4K and leaving 530 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #770.

Verus Capital Partners first reported a position in SNY in Q4 2019 and has held it in 2 quarters since. The position peaked at $73K in Q4 2019. 547 funds tracked by Wall St. Rank hold SNY as of Q1 2020.

  • Verus Capital Partners held 530 shares of Sanofi worth $23K as of Q1 2020.
  • Verus Capital Partners sold 928 Sanofi shares in Q1 2020, an estimated $44.4K.
  • Sanofi made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #770 holding.
  • Verus Capital Partners first reported a position in Sanofi in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Sanofi position peaked at $73K in Q4 2019.
  • 547 funds tracked by Wall St. Rank held Sanofi as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.